Labcorp Holdings annual revenue
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Labcorp Holdings Revenue Growth & History (LH)
Labcorp Holdings reported $13.95B in revenue for fiscal 2025, an increase of 7.25% from the previous fiscal year.
View full Labcorp Holdings company overviewLabcorp Holdings annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $13.95B | $942.8M | +7.25% |
| 2024 | 2024-12-31 | $13.01B | $847.3M | +6.97% |
| 2023 | 2023-12-31 | $12.16B | $297.7M | +2.51% |
| 2022 | 2022-12-31 | $11.86B | −$1.27B | −9.68% |
| 2021 | 2021-12-31 | $13.14B | −$842.4M | −6.03% |
| 2020 | 2020-12-31 | $13.98B | $2.42B | +20.98% |
| 2019 | 2019-12-31 | $11.55B | $221.4M | +1.95% |
| 2018 | 2018-12-31 | $11.33B | $1.03B | +9.95% |
| 2017 | 2017-12-31 | $10.31B | $755.1M | +7.90% |
| 2016 | 2016-12-31 | $9.55B | $872.8M | +10.06% |
| 2015 | 2015-12-31 | $8.68B | $2.67B | +44.39% |
| 2014 | 2014-12-31 | $6.01B | $203.3M | +3.50% |
| 2013 | 2013-12-31 | $5.81B | $136.9M | +2.41% |
| 2012 | 2012-12-31 | $5.67B | $129.1M | +2.33% |
| 2011 | 2011-12-31 | $5.54B | $538.4M | +10.76% |
| 2010 | 2010-12-31 | $5.00B | $309.2M | +6.59% |
| 2009 | 2009-12-31 | $4.69B | $189.5M | +4.21% |
| 2008 | 2008-12-31 | $4.51B | $437.0M | +10.74% |
| 2007 | 2007-12-31 | $4.07B | — | — |
Labcorp Holdings quarterly revenue
Q2.08
Q3.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.73B | $203.8M | +5.78% |
| Q1 2026 | 2026-03-31 | $3.54B | $192.5M | +5.75% |
| Q4 2025 | 2025-12-31 | $3.52B | $186.4M | +5.60% |
| Q3 2025 | 2025-09-30 | $3.56B | $281.5M | +8.58% |
| Q2 2025 | 2025-06-30 | $3.53B | $306.4M | +9.51% |
| Q1 2025 | 2025-03-31 | $3.35B | $168.5M | +5.30% |
| Q4 2024 | 2024-12-31 | $3.33B | $296.1M | +9.76% |
| Q3 2024 | 2024-09-30 | $3.28B | $225.2M | +7.37% |
| Q2 2024 | 2024-06-30 | $3.22B | $187.2M | +6.17% |
| Q1 2024 | 2024-03-31 | $3.18B | $138.8M | +4.57% |
| Q4 2023 | 2023-12-31 | $3.03B | $858.8M | +39.49% |
| Q3 2023 | 2023-09-30 | $3.06B | $190.0M | +6.63% |
| Q2 2023 | 2023-06-30 | $3.03B | $110.7M | +3.79% |
| Q1 2023 | 2023-03-31 | $3.04B | −$861.8M | −22.10% |
| Q4 2022 | 2022-12-31 | $2.17B | $1.10B | +102.98% |
| Q3 2022 | 2022-09-30 | $2.87B | −$1.20B | −29.43% |
| Q2 2022 | 2022-06-30 | $2.92B | −$917.7M | −23.89% |
| Q1 2022 | 2022-03-31 | $3.90B | −$261.9M | −6.29% |
| Q4 2021 | 2021-12-31 | $1.07B | −$3.42B | −76.14% |
| Q3 2021 | 2021-09-30 | $4.06B | $166.5M | +4.27% |
| Q2 2021 | 2021-06-30 | $3.84B | $1.07B | +38.71% |
| Q1 2021 | 2021-03-31 | $4.16B | $1.34B | +47.37% |
| Q4 2020 | 2020-12-31 | $4.49B | $1.54B | +52.02% |
| Q3 2020 | 2020-09-30 | $3.90B | $967.6M | +33.04% |
| Q2 2020 | 2020-06-30 | $2.77B | −$112.9M | −3.92% |
| Q1 2020 | 2020-03-31 | $2.82B | $32.6M | +1.17% |
| Q4 2019 | 2019-12-31 | $2.95B | $165.9M | +5.95% |
| Q3 2019 | 2019-09-30 | $2.93B | $97.2M | +3.43% |
| Q2 2019 | 2019-06-30 | $2.88B | $15.4M | +0.54% |
| Q1 2019 | 2019-03-31 | $2.79B | −$57.1M | −2.00% |
| Q4 2018 | 2018-12-31 | $2.79B | $42.8M | +1.56% |
| Q3 2018 | 2018-09-30 | $2.83B | $209.9M | +8.01% |
| Q2 2018 | 2018-06-30 | $2.87B | $338.1M | +13.37% |
| Q1 2018 | 2018-03-31 | $2.85B | $434.6M | +18.01% |
| Q4 2017 | 2017-12-31 | $2.74B | $357.4M | +14.97% |
| Q3 2017 | 2017-09-30 | $2.62B | $206.7M | +8.56% |
| Q2 2017 | 2017-06-30 | $2.53B | $97.5M | +4.01% |
| Q1 2017 | 2017-03-31 | $2.41B | −$7.23B | −74.97% |
| Q4 2016 | 2016-12-31 | $2.39B | $142.5M | +6.35% |
| Q3 2016 | 2016-09-30 | $2.41B | $97.4M | +4.20% |
| Q2 2016 | 2016-06-30 | $2.43B | $161.6M | +7.12% |
| Q1 2016 | 2016-03-31 | $9.64B | $7.85B | +437.69% |
| Q4 2015 | 2015-12-31 | $2.24B | $732.1M | +48.40% |
| Q3 2015 | 2015-09-30 | $2.32B | $765.5M | +49.33% |
| Q2 2015 | 2015-06-30 | $2.27B | $752.7M | +49.64% |
| Q1 2015 | 2015-03-31 | $1.79B | −$4.22B | −70.17% |
| Q4 2014 | 2014-12-31 | $1.51B | $75.7M | +5.27% |
| Q3 2014 | 2014-09-30 | $1.55B | $89.6M | +6.13% |
| Q2 2014 | 2014-06-30 | $1.52B | $48.2M | +3.28% |
| Q1 2014 | 2014-03-31 | $6.01B | $4.57B | +317.21% |
| Q4 2013 | 2013-12-31 | $1.44B | $31.7M | +2.26% |
| Q3 2013 | 2013-09-30 | $1.46B | $42.8M | +3.02% |
| Q2 2013 | 2013-06-30 | $1.47B | $44.8M | +3.15% |
| Q1 2013 | 2013-03-31 | $1.44B | $17.6M | +1.24% |
| Q4 2012 | 2012-12-31 | $1.41B | $39.2M | +2.87% |
| Q3 2012 | 2012-09-30 | $1.42B | $14.9M | +1.06% |
| Q2 2012 | 2012-06-30 | $1.42B | $20.1M | +1.43% |
| Q1 2012 | 2012-03-31 | $1.42B | $54.9M | +4.01% |
| Q4 2011 | 2011-12-31 | $1.37B | $70.7M | +5.46% |
| Q3 2011 | 2011-09-30 | $1.40B | $128.0M | +10.03% |
| Q2 2011 | 2011-06-30 | $1.40B | $164.9M | +13.32% |
| Q1 2011 | 2011-03-31 | $1.37B | $174.8M | +14.64% |
| Q4 2010 | 2010-12-31 | $1.30B | $130.3M | +11.18% |
| Q3 2010 | 2010-09-30 | $1.28B | $91.4M | +7.71% |
| Q2 2010 | 2010-06-30 | $1.24B | $49.6M | +4.17% |
| Q1 2010 | 2010-03-31 | $1.19B | $37.9M | +3.28% |
| Q4 2009 | 2009-12-31 | $1.17B | — | — |
| Q3 2009 | 2009-09-30 | $1.19B | $50.0M | +4.40% |
| Q2 2009 | 2009-06-30 | $1.19B | $41.0M | +3.57% |
| Q1 2009 | 2009-03-31 | $1.16B | — | — |
| Q3 2008 | 2008-09-30 | $1.14B | — | — |
| Q2 2008 | 2008-06-30 | $1.15B | — | — |
Labcorp Holdings revenue growth trends
Over the last five reported fiscal years, revenue declined from $13.98B to $13.95B, a compound annual decline of 0.04%. Labcorp Holdings's latest reported quarter, Q2 2026, generated $3.73B in revenue, an increase of 5.78% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...
